Who Paid My Doc
Fine-Real
Research payments
$849,693
Through program year 2023, $849,693 in research payments was reported against Fine-Real, across 201 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $849,693 | 201 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ronald Graf Tacoma, WA Named on 12 payments
- Michael Quadrini Huntsville, AL Named on 12 payments
- N. Roxana Neyra Phoenix, AZ Named on 12 payments
- William Yang Northridge, CA Named on 12 payments
- Gloria Ortiz McAllen, TX Named on 12 payments
- Vonda Houchin Harrisburg, AR Named on 11 payments
- Alan Parsa Honolulu, HI Named on 10 payments
- Joseph Ravid Port Charlotte, FL Named on 9 payments
- Leo Ovadje Stockbridge, GA Named on 9 payments
- Raffi Minasian Glendale, CA Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.